Good afternoon cwamit. I just wanted to say that I like your Posts, which do increase my understanding of my investment in Peak.
like you, I have high hopes for this Company, and agree that our best way forward is to have Shenghe as an agreeable Partner. Also agree with your view that we should start getting dividends in about three years, with the share price increasing in advance of that.
Regarding the last Company Announcement, there is a sub-section headed “Explanatory Statements” and I ask if you noticed on pages 5 and 6 of that Statement that there were a number of conditions which had to be “met or waived” before we gave Shenghe the right to 100% of the mines product (Heavy Mineral Concentrate) for 7 years? Condition 5, or (v), was that there had to be in place an arrangement for - “funding the construction, development of the project plus satisfactory draw-down arrangements”. Then a little further down was the sentence - “ condition (v) had been satisfied or waived”.
So two possibilities. If it has been “satisfied” it means that all funding has been obtained , presumably from Shenghe though they are not specifically mentioned. If this is true it is hugely important !!!
The second possibility is that the condition has been “waived” In which case we have lost a valuable negotiating chip
Though I hasten to add that if it has been “waived” I would think our Board of Directors would have good reasons for doing so.
Anyway fellow share holders, stay happy, for big wheels are turning and the sun is about to shine on us.
Wichetty.
- Forums
- ASX - By Stock
- PEK
- Ann: Notice of General Meeting/Proxy Form - Offtake Agreement
PEK
peak rare earths limited
Add to My Watchlist
1.79%
!
27.5¢

Ann: Notice of General Meeting/Proxy Form - Offtake Agreement, page-15
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
27.5¢ |
Change
-0.005(1.79%) |
Mkt cap ! $96.83M |
Open | High | Low | Value | Volume |
28.0¢ | 28.5¢ | 27.5¢ | $295.2K | 1.052M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 379024 | 27.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.0¢ | 91331 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 379024 | 0.275 |
5 | 413778 | 0.270 |
6 | 369000 | 0.265 |
7 | 1526383 | 0.260 |
4 | 333999 | 0.250 |
Price($) | Vol. | No. |
---|---|---|
0.280 | 51331 | 5 |
0.285 | 315500 | 5 |
0.290 | 1866 | 1 |
0.300 | 153029 | 3 |
0.305 | 40000 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
PEK (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online